CLINICAL_TRIALS
trial_result
· 2024-06-12
Clinical Trial Update: A Study to Investigate the Efficacy of Fenebrutinib in Relapsing Multiple Sclerosis (RMS) [Phase 2]
Summary
Phase 2 clinical trial evaluating the efficacy of Fenebrutinib in Relapsing Multiple Sclerosis. Results were posted in 2024.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Relapsing Multiple Sclerosis | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-06-12